Ligand Reports Third Quarter 2018 Financial Results
Go back to Ligand Reports Third Quarter 2018 Financial Results| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 265.97 +3.80 (1.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $262.17 | 52 Week High | $139.79 | |||
| Open | $258.99 | 52 Week Low | $82.07 | |||
| Day High | $268.56 | P/E | 618.53 | |||
| Day Low | $258.00 | EPS | $0.43 | |||
| Volume | 411,552 | |||||
| Vernalis Plc Sponsored ADR (AMEX: VNLPY) | Delayed: 0.38 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.38 | 52 Week High | $2.43 | |||
| Open | $0.23 | 52 Week Low | $1.09 | |||
| Day High | $0.38 | P/E | N/A | |||
| Day Low | $0.38 | EPS | $0.00 | |||
| Volume | 8,366 | |||||
